• 제목/요약/키워드: Acanthopanax Senticosus Extract

검색결과 73건 처리시간 0.027초

가시오가피 열수추출물의 전신성 Anaphylaxis에 대한 억제효과 (Effect of Hot Water Extract from Acanthopanax senticosus on Systemic Anaphylaxis)

  • 윤택준;이석원;신광순;최원희;황수현;서상희;김성훈;박우문
    • 한국식품과학회지
    • /
    • 제34권3호
    • /
    • pp.518-523
    • /
    • 2002
  • 마우스에서 가시오가피 열수추출물(GF-2)의 투여는 compound 48/80에 의하여 유도되는 전신성 anaphylactic shock 및 혈중 histamine과 호산구의 생산을 GF-2 농도 의존적으로 억제하였을 뿐 아니라, 마우스 복강세포에서 LPS에 의하여 유도되는 $TNF-{\alpha}$의 생산을 유의적으로 감소시켰다. 또한, 마우스에 항원으로서 ovalbumin(OVA)와 adjuvant로서 aluminium hydroxide를 사용하여 면역 후, OVA에 대한 IgG1 및 IgE 항체의 역가를 조사한 결과, GF-2의 투여는 이들 항체의 생산을 억제하였다. 이 결과는 GF-2를 항원 특이적 혹은 비특이적인 알러지 반응에 응용할 수 있는 소재로 개발 가능성 있음을 제시하였다.

청아원가감 추출물이 난소적출로 유발된 흰쥐의 골다공증 모델이 미치는 영향 (Effect of Cheongawongagam Extract on the Ovariectomized Rat Model of Osteoporosis)

  • 윤지원;이현
    • 동의생리병리학회지
    • /
    • 제34권1호
    • /
    • pp.14-23
    • /
    • 2020
  • This study was conducted to evaluate the efficacy of Cheongawongagam on osteoporosis rat. A total of 35 rats were divided into seven groups; Normal control(SD-Nr), experimental control group(OVX-CTL), positive control group(OVX-17β-E2) and herb extracts group[Eucommia ulmoides(OVX-EU-E), Juglandis semen(OVX-JR-SE), Acanthopanax senticosus(OVX-AS-E) extract and Cheongawongagam extracts(OVX-JAEG-E)]. All control group, and herb extracts group were ovariectomized. After the 3 weeks recovery period, herb extract group were orally administered 200 mg / kg of the EU-E, JR-SE, AS-E and JAEG-E for 12 weeks. In the OVX-CTL, 17β-estradiol(E2) was administered subcutaneously on the back of the rats at a dose of 0.03 ug/sc. Their body weight, serum total cholesterol, triglyceride, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), Leukotriene B4 (LTB4), calcium (Ca), estradiol, osteocalcin, and deoxypyridinoline (DPD) concentration were measured. Also, we investigated mRNA expression of inflammatory cytokine, MMP-2, MMP-9, and bone tissue. As a result, total cholesterol was significantly decreased in the OVX-AS-E and OVX-JAEG-E. ALP was significantly increased and osteocalcin, DPD was significantly decreased in OVX-JAEG-E. The expression of inflammatory mediators (TNF-α, IL-1β, LTB4, COX-2, NOS-2), inflammatory cytokines IL-1β and MMP-9 mRNA were significantly decreased in OVX-JAEG-E. Histologic examination of the femur showed that bone mineral density, and bone mass were increased and bone marrow were decreased in the OVX-JAEG-E group. The above experiment shows that cheongawongagam extract were effective in the prevention and treatment of osteoporosis.

Proliferative and Inhibitory Activity of Siberian ginseng (Eleutherococcus senticosus) Extract on Cancer Cell Lines; A-549, XWLC-05, HCT-116, CNE and Beas-2b

  • Cichello, Simon Angelo;Yao, Qian;Dowell, Ashley;Leury, Brian;He, Xiao-Qiong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권11호
    • /
    • pp.4781-4786
    • /
    • 2015
  • Siberian ginseng (Eleutherococcus senticosus) is used primarily as an adaptogen herb and also for its immune stimulant properties in Western herbal medicine. Another closely related species used in East Asian medicine systems i.e. Kampo, TCM (Manchuria, Korea, Japan and Ainu of Hokkaido) and also called Siberian ginseng (Acanthopanax senticosus) also displays immune-stimulant and anti-cancer properties. These may affect tumour growth and also provide an anti-fatigue effect for cancer patients, in particular for those suffering from lung cancer. There is some evidence that a carbohydrate in Siberian ginseng may possess not only immune stimulatory but also anti-tumour effects and also display other various anti-cancer properties. Our study aimed to determine the inhibitory and also proliferative effects of a methanol plant extract of Siberan ginseng (E. senticosus) on various cancer and normal cell lines including: A-549 (small cell lung cancer), XWLC-05 (Yunnan lung cancer cell line), CNE (human nasopharyngeal carcinoma cell line), HCT-116 (human colon cancer) and Beas-2b (human lung epithelial). These cell lines were treated with an extract from E. senticosus that was evaporated and reconstituted in DMSO. Treatment of A-549 (small cell lung cancer) cells with E. senticosus methanolic extract showed a concentration-dependent inhibitory trend from $12.5-50{\mu}g/mL$, and then a plateau, whereas at 12.5 and $25{\mu}g/mL$, there is a slight growth suppression in QBC-939 cells, but then a steady suppression from 50, 100 and $200{\mu}g/mL$. Further, in XWLC-05 (Yunnan lung cancer cell line), E. senticosus methanolic extract displayed an inhibitory effect which plateaued with increasing dosage. Next, in CNE (human nasopharyngeal carcinoma cell line) there was a dose dependent proliferative response, whereas in Beas-2 (human lung epithelial cell line), an inhibitory effect. Finally in colon cancer cell line (HCT-116) we observed an initially weak inhibitory effect and then plateau.

STZ으로 유발된 당뇨쥐에 대한 식물추출 혼합물의 항당뇨 상승효과 (Antidiabetic Synergetic Effects of Plant Extract-Mixtures in Streptozotocin-Diabetes Rats)

  • 노상근;김종해;최원철
    • 생명과학회지
    • /
    • 제19권3호
    • /
    • pp.334-342
    • /
    • 2009
  • 본 연구는 streptozotocin (STZ)으로 당뇨를 유발한 실험쥐에 대한 Psidium guajava L. 잎(Pg), Lagerstroemia speciosa L. 잎(Ls) 추출물 그리고 혼합물 A (Pg, Ls, Morus indica L. 잎 추출물, Pinus densiflora needles 추출물, Acanthopanax senticosus M. roots 추출물)의 효과를 조사하였다. 4주간 streptozotocin (STZ)으로 당뇨를 유발한 실험쥐에 이들 추출물을 섭취시킨 결과 Pg, Ls 그리고 혼합물 A의 섭취는 당뇨 대조군에 비해 혈당을 각각 20%, 14% 그리고 24% 감소시켰다. 또한 이들 추출물의 섭취는 총 콜레스트롤, 중성지방, 유리지방산을 감소시켰고 인슐린과 HDL-콜레스트롤을 효과적으로 증가시켰다. 결론적으로 혼합물 A는 Pg와 Ls 추출물에 비해 혈당 및 지질 감소, 인슐린 증가 효과 그리고 기능적으로 손상된 베타세포의 회복이 더 높은 것으로 나타났다. 따라서 혼합물 A는 개별적으로 사용한 Pg와 Ls 추출물에 비해 더욱 유익한 상승효과를 발휘하는 것으로 증명되었다.

가시오가피 버섯균사체 발효물의 기능성 식품 소재 개발 (Development of Functional Food Materials from Acanthopanax senticosus-Fermented Mushroom Mycelia)

  • 조주현;최구희;박인재;백순옥;김형하;김충식
    • 한국식품영양과학회지
    • /
    • 제43권3호
    • /
    • pp.411-418
    • /
    • 2014
  • 가시오가피(Acanthopanax senticosus)의 잎과 줄기를 천연물배지로 발효미생물인 영지버섯, 노루궁뎅이버섯 및 상황버섯균사체를 각각 최적조건으로 발효하여 3종의 가시오가피-버섯발효물인 가시오가피 영지버섯균사체 발효물, 가시오가피 노루궁뎅이버섯균사체 발효물, 가시오가피 상황버섯균사체 발효물을 얻었으며 이를 건강기능식품 소재로서 이용하고자 하였다. 우선적으로 배양용 시험관과 실험실용 배양병을 사용하여 버섯균사체별 가시오가피의 천연배지로서 최적혼합비율을 검토한 결과 영지버섯균사체, 노루궁뎅이버섯균사체 및 상황버섯균사체의 가시오가피 줄기와 잎의 혼합비율을 각각 80:20, 50:50, 50:50으로 확립하였으며, 이 조건을 가지고 산업용 배양포트(2,000 mL)에서의 최적배양시간을 검토한 결과 영지버섯균사체 14일, 노루궁뎅이버섯균사체 40일, 상황버섯균사체 30일로 확립하였다. 상기와 같이 최적화된 조건으로 배양된 3종의 가시오가피 버섯균사체 발효물들을 물과 70% 에탄올로 추출, 여과, 농축, 동결건조를 수행하여 가시오가피 버섯균사체 발효물 추출분말인 열수추출물(FM-5111, FM-5121, FM-5131)과 70% 에탄올추출물(FM-5112, FM-5122, FM-5132)을 얻었다. 이 가시오가피 버섯균사체 발효물 추출분말의 eleutheroside B와 eleutheroside E를 분석한 결과, eleutheroside B는 FM-5111 $0.050{\pm}0.003mg/g$, FM-5121 $0.067{\pm}0.001mg/g$, FM-5131 $0.026{\pm}0.001mg/g$, FM-5112 $0.038{\pm}0.002mg/g$, FM-5122 $0.053{\pm}0.005mg/g$, FM-5132 $0.025{\pm}0.001mg/g$의 함량을 나타내었고, eleutheroside E는 FM-5111 $0.052{\pm}0.014mg/g$, FM-5121 $0.047{\pm}0.003mg/g$, FM-5131 $0.078{\pm}0.003mg/g$, FM-5112 $0.045{\pm}0.002mg/g$, FM-5122 $0.040{\pm}0.002mg/g$, FM-5132 $0.080{\pm}0.011mg/g$의 함량을 보였으며, ${\beta}$-glucan의 경우 FM-5111 $4.47{\pm}0.14%$, FM-5121 $3.41{\pm}0.15%$, FM-5131 $4.15{\pm}0.06%$, FM-5112 $5.18{\pm}0.36%$, FM-5122 $3.74{\pm}0.40%$, FM-5132 $4.37{\pm}0.32%$의 함량이 측정되었다.

지골피, 동충하초, 가시오가피 혼합 추출물의 항당뇨 작용 (Anti-diabetic Effects of Mixed Extracts from Lycium chinense, Cordyceps militaris, and Acanthopanax senticosus)

  • 김대중;김정미;김태혁;백종미;김현숙;최면
    • 한국자원식물학회지
    • /
    • 제23권5호
    • /
    • pp.423-429
    • /
    • 2010
  • 본 연구에서는 유전적으로 제2형 당뇨를 가진 Goto-Kakizaki 흰쥐의 간 세포액에 함유된 당대사 관련 주요 효소인 glucokinase(GK)와 acetyl-CoA carboxylase(ACC)의 활성 및 $\alpha$-glucosidase 저해 활성을 측정하였다. 사용된 소재로는 지골피(Lycium chinense), 동충하초(Cordyceps militaris), 가시오가피(Acanthopanax senticosus)를 선정하였고, 이를 단독으로 사용하기 보다는 유효성분의 항당뇨 효능에 대한 상승효과를 알아보기 위하여 일정비율로 혼합하였다. 각 소재들을 일정 비율로 혼합한 모든 추출물에서 GK와 ACC의 활성이 증가하였으며, 가시오가피와 동충하초의 혼합 비율이 높아질수록 효소의 활성 증가율도 높아진 것으로 나타났다. 이는 지골피와 가시오가피, 동충하초의 상승작용 때문으로 사료된다. $\alpha$-glucosidase의 저해 활성은 JDG 5(1:6:6) 처리군에서 acarbose 보다 높은 억제율을 나타내었다. 결론적으로 지골피, 가시오가피, 동충하초의 혼합 비율이 1:6:6 일 때 당대사 관련 효소인 GK와 ACC 효소를 활성화시키고, $\alpha$-glucosidase의 활성을 저해하여 흡수된 당의 이용에 유리하게 작용함으로써 항당뇨 효과를 나타낼 수 있을 것으로 사료된다.

Platelet Anti-Aggregating Plant Materials

  • YunChoi, Hye-Sook;Kim, Jae-Hoon;Kim, Sun-Ok;Lee, Jong-Ran
    • 생약학회지
    • /
    • 제17권2호
    • /
    • pp.161-167
    • /
    • 1986
  • The smear method developed by Velaskar and Chitre was modified to allow the screening of plant extracts and/or fractions for platelet anti-aggregating activity. The modified smear method was also found suitable for massive screening of pure compounds. Sample fractions prepared from various plant extracts were examined for their effects against ADP, arachidonic acid (AA) or collagen induced platelet aggregations. Several solvent fractions of plant extracts including water fraction prepared from the methanol extract of Acanthopanax sp. was inhibitory against rat platelet aggregations. The activity guided treatments and fractionations of the water fraction from A. senticosus Max yielded two anti-platelet aggregatory substances, 3, 4-dihydroxybenzoic acid (I) and its artefact ethyl 3, 4-dihydroxybenzoate(II). The inhibitory activities of I and II against rat platelet aggregation were compared with that of aspirin, a known inhibitor of platelet aggregation. Discussions also included the results of the investigations on the structural activity relationships among the various dihydroxybenzoic acid derivatives against platelet aggregations induced by either one of ADP, AA or collagen.

  • PDF

Dietary Supplementation with Acanthopanax senticosus Extract Modulates Gut Microflora in Weaned Piglets

  • Yin, Fugui;Yin, Yulong;Kong, Xiangfeng;Liu, Yulan;He, Qinghua;Li, Tiejun;Huang, Ruilin;Hou, Yongqing;Shu, Xugang;Tan, Liangxi;Chen, Lixiang;Gong, Jianhua;Kim, Sung Woo;Wu, Guoyao
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제21권9호
    • /
    • pp.1330-1338
    • /
    • 2008
  • This study was conducted to investigate the effects of Acanthopanax senticosus extract (ASE) as a dietary additive on gut microflora in weaned piglets. A total of sixty pigs were weaned at 21 d of age (BW = $5.64{\pm}0.23kg$) and allocated on the basis of BW and litter to three dietary treatments in a randomized complete block design. The dietary treatments were: control group (basal diet), antibiotics group (basal diet+0.02% colistin), and ASE group (basal diet+0.1% ASE). On d 7, 14 and 28 after consuming the experimental diets, five piglets per group were sacrificed and then the contents from the jejunum, ileum and cecum were collected to determine changes in the microbial community by using a polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) technique and estimating the contents of Lactobacillus and E. coli by in vitro culturing methods. The results showed that the ASE promoted the microflora diversity in the cecum. Enumeration of bacteria in the gut contents showed that the number of Lactobacillus increased (p<0.05), while that of E. coli decreased (p<0.05) when compared with the other 2 groups as the days of age progressed post-weaning. These findings suggested that the ASE, as a substitute for dietary antimicrobial products, could improve the development of the normal gut microflora and suppress bacterial pathogens, and effectively promote a healthy intestinal environment.